2012 BIOCOM Board of Directors

CHAIR: David Webb, Ph.D., Celgene*

VICE CHAIR: Stephen Ferruolo, J.D., Ph.D., USD School of Law*

CHAIR ELECT: Magda Marquet, Ph.D., AltheaDx*

VICE PRESIDENT AND GENERAL COUNSEL: Lisa Haile, Ph.D., DLA Piper*

VICE PRESIDENT – FINANCE: Daniel Kleeburg, Ernst & Young*

VICE PRESIDENT AND SECRETARY: Carin Canale-Theakston, Canale Communications*

VICE PRESIDENT – INDUSTRY: Theodore Schroeder, Cadence Pharmaceuticals*

PRESIDENT AND CEO: Joe Panetta, BIOCOM*

Vince Anido, Ph.D., ISTA Pharmaceuticals

Martin Birkhofer, Bristol-Myers Squibb R&D

Scott Beal, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo

Terrance J. Bruggeman, BioTork, LLC

Daniel Burgess, Rempex Pharmaceuticals, Inc.

Lawrence Cohn, Stradling Yocca Carlson & Rauth

John M. Dunn, Biogen Idec, Inc.

Geoffrey S. Eich, Amgen

M. Wainwright Fishburn Jr., Cooley*

Don Fitzgerald, Genentech, Inc.

Jack Florio, Brinson Patrick

Scott Foote, Square 1 Bank

Kieran Gallahue, CareFusion*

Alan Gold, BioMed Realty Trust

Jeffrey W. Guise, Ph.D., Wilson, Sonsini, Goodrich & Rosati

Jason Hannon, NuVasive

Richard Henson, Source Scientific, Inc.

Scott Huennekens, Volcano Corporation

Guy J. Iannuzzi, 321 Medical Launch

Brent D. Jacobs, Cushman & Wakefield

David Kabakoff, Ph.D., Sofinnova Ventures

Michael Kamdar

Dave Karlman, Otologic Pharmaceutics

Richard Kaufman, Foley & Lardner LLP

Kevin Larkin, TherOx

Jack Lief, Arena Pharmaceuticals, Inc.*

Jacob Levin, Ph.D., UC Irvine

Harry Leonhardt, Amylin Pharmaceuticals

Steven Mento, Ph.D., Conatus Pharmaceuticals, Inc.*

William Molloie, PwC

Paul Negulescu, Ph.D., Vertex Pharmaceuticals

Tina Nova, Ph.D., Genoptix, Inc. a Novartis Company

John Parrish, BioVascular Inc.

John C. Reed, M.D., Ph.D., Burnham Institute for Medical Research

Trindl Reeves, Barney & Barney LLC*

Herm Rosenman, Gen-Probe, Inc.

Theodore D. Roth, Roth Capital Partners LLC

Scott Salka

James Schaeffer, Ph.D., Merck Research Laboratories

Christophe Schilling, Genomatica, Inc.

Timothy Scott, Pharmatek Laboratories, Inc.

Bhasker Shetty, Pfizer La Jolla

Larry Stambaugh, Cryoport*

Mark Stevenson, Life Technologies*

Roger Stoll, Ph.D., Cortex Pharmaceuticals

Nikki Vogt, Deloitte LLP

Scott N. Wolfe, Latham & Watkins LLP

Lawrence Cohn, Stradling Yocca Carlson & Rauth

Randall E. Woods*

Kleanthis Xanthopoulos, Ph.D., Regulus Therapeutics

LIFE DIRECTORS:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

David Hale, Somaxon Pharmaceuticals

Duane J. Roth, CONNECT

BIOCOM Board Members-Ex-Officio:

Ruben Barrales, San Diego Regional Chamber of Commerce

David Brenner, M.D. UCSD Health Sciences

Mark Cafferty, San Diego Regional EDC

Constance Carroll, Ph.D., San Diego Community College District

Gary Friedman, Esq., The Agouron Institute

Catherine Mackey, Ph.D., MindPiece Partners

Peter Preuss, The Preuss Foundation

Bob Sullivan, Ph.D., UCSD Rady School of Management

*Executive Committee